WallStreetZenWallStreetZen

NASDAQ: EVO
Evotec Se Stock

$7.81+0.36 (+4.83%)
Updated Mar 27, 2024
EVO Price
$7.81
Fair Value Price
$4.07
Market Cap
$2.77B
52 Week Low
$6.83
52 Week High
$13.49
P/E
N/A
P/B
2.28x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.98
Operating Cash Flow
N/A
Beta
1.51
Next Earnings
Mar 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

EVO Overview

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EVO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EVO ($7.81) is overvalued by 91.67% relative to our estimate of its Fair Value price of $4.07 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
EVO ($7.81) is not significantly undervalued (91.67%) relative to our estimate of its Fair Value price of $4.07 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EVO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more EVO due diligence checks available for Premium users.

Be the first to know about important EVO news, forecast changes, insider trades & much more!

EVO News

Valuation

EVO fair value

Fair Value of EVO stock based on Discounted Cash Flow (DCF)
Price
$7.81
Fair Value
$4.07
Overvalued by
91.67%
EVO ($7.81) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EVO ($7.81) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

EVO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
0x
Industry
53.92x
Market
44.45x

EVO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.28x
Industry
2.2x
EVO is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EVO's financial health

Profit margin

Revenue
$208.8M
Net Income
-$41.4M
Profit Margin
-19.8%

Assets to liabilities

Assets
$2.4B
Liabilities
$1.2B
Debt to equity
0.98
EVO's short-term assets ($999.15M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EVO's short-term assets ($999.15M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EVO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$22.1M
Investing
-$16.8M
Financing
$46.1M

EVO vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
EVO$2.77B+4.83%N/A2.28x
INDV$2.92B+4.08%2,141.00xN/A
HCM$2.94B+1.20%28.08x4.02x
ALVO$3.38B+1.44%-5.22x-3.63x
AMPH$2.09B+0.72%15.27x3.27x

Evotec Se Stock FAQ

What is Evotec Se's quote symbol?

(NASDAQ: EVO) Evotec Se trades on the NASDAQ under the ticker symbol EVO. Evotec Se stock quotes can also be displayed as NASDAQ: EVO.

If you're new to stock investing, here's how to buy Evotec Se stock.

What is the 52 week high and low for Evotec Se (NASDAQ: EVO)?

(NASDAQ: EVO) Evotec Se's 52-week high was $13.49, and its 52-week low was $6.83. It is currently -42.11% from its 52-week high and 14.28% from its 52-week low.

How much is Evotec Se stock worth today?

(NASDAQ: EVO) Evotec Se currently has 177,185,736 outstanding shares. With Evotec Se stock trading at $7.81 per share, the total value of Evotec Se stock (market capitalization) is $2.77B.

Evotec Se stock was originally listed at a price of $8.64 in Oct 19, 2022. If you had invested in Evotec Se stock at $8.64, your return over the last 1 years would have been -9.55%, for an annualized return of -9.55% (not including any dividends or dividend reinvestments).

How much is Evotec Se's stock price per share?

(NASDAQ: EVO) Evotec Se stock price per share is $7.81 today (as of Mar 27, 2024).

What is Evotec Se's Market Cap?

(NASDAQ: EVO) Evotec Se's market cap is $2.77B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Evotec Se's market cap is calculated by multiplying EVO's current stock price of $7.81 by EVO's total outstanding shares of 177,185,736.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.